Okay.
This is the last point I'd like to make. In terms of investor rights, the TPP does go beyond NAFTA, and there are some very important issues here that we need to address, particularly, for example, the Eli Lilly challenge to Canada's court decision regarding its patents. The TPP proposes essentially to fold in IPRs within the definition of intellectual property, which is far beyond what we have in NAFTA and would expose us to further trade challenges.
Thank you for your tolerance.